Cystic Fibrosis-related Liver Disease is Associated With Increased Disease Burden and Endocrine Comorbidities

Cystic fibrosis-related liver disease (CFLD) is the leading nonpulmonary cause of mortality in cystic fibrosis (CF). We evaluated and compared the burden of disease and nonrespiratory comorbidities of those with severe CFLD and those without (noCFLD). A retrospective nationwide (Australia) longitudi...

Full description

Saved in:
Bibliographic Details
Published inJournal of pediatric gastroenterology and nutrition Vol. 70; no. 6; p. 796
Main Authors Singh, Harveen, Coffey, Michael J, Ooi, Chee Y
Format Journal Article
LanguageEnglish
Published United States 01.06.2020
Online AccessGet full text

Cover

Loading…
Abstract Cystic fibrosis-related liver disease (CFLD) is the leading nonpulmonary cause of mortality in cystic fibrosis (CF). We evaluated and compared the burden of disease and nonrespiratory comorbidities of those with severe CFLD and those without (noCFLD). A retrospective nationwide (Australia) longitudinal review (from 1998 to 2016) of severe CFLD patients compared with noCFLD controls (matched 1 : 1 for age, genotype, pancreatic insufficiency, and center). One hundred sixty-six patients with severe CFLD and 166 with noCFLD were identified. Forced expiratory volume in 1 second percentage of predicted (FEV1%) was significantly lower in CFLD than noCFLD across all ages (estimate [SE] -6.05% [2.12]; P = 0.004). Median (IQR) hospitalizations per patient per year were higher in CFLD than noCFLD for: respiratory indications (0.6 [0.2-1.3] vs 0.4 [0.1-0.9]; P = 0.002); gastrointestinal indications (0.09 [0-0.2] vs 0 [0-0.05]; P < 0.001); and other indications (0.05 [0-0.2] vs 0 [0-0.1]; P = 0.03). In the CFLD cohort, there was increased use of nasogastric (12.6% vs 5.4%; OR 2.51 [95% CI 1.06-6.46]; P = 0.03) and gastrostomy nutritional supplementation (22.9% vs 13.2%; OR 1.93 [95% CI 1.05-3.63]; P = 0.03). Additionally, the CFLD cohort had a higher frequency of bone diseases, osteopenia (26.5% vs 16.8%; OR 1.77 [95%CI 1.01-3.15]; P = 0.04) and osteoporosis (16.2% vs 8.4%; OR 2.1 [95% CI 1.01-4.52]; P = 0.04), as well as CF-related diabetes (38.5% vs 19.2%; OR 2.61 [95% CI 1.55-4.47]; P = 0.001). Patients with severe CFLD have greater disease burden, with higher number of hospitalizations (both respiratory and nonrespiratory indications), nutritional interventions, and are at higher risk of CF-related bone disease and diabetes.
AbstractList Cystic fibrosis-related liver disease (CFLD) is the leading nonpulmonary cause of mortality in cystic fibrosis (CF). We evaluated and compared the burden of disease and nonrespiratory comorbidities of those with severe CFLD and those without (noCFLD). A retrospective nationwide (Australia) longitudinal review (from 1998 to 2016) of severe CFLD patients compared with noCFLD controls (matched 1 : 1 for age, genotype, pancreatic insufficiency, and center). One hundred sixty-six patients with severe CFLD and 166 with noCFLD were identified. Forced expiratory volume in 1 second percentage of predicted (FEV1%) was significantly lower in CFLD than noCFLD across all ages (estimate [SE] -6.05% [2.12]; P = 0.004). Median (IQR) hospitalizations per patient per year were higher in CFLD than noCFLD for: respiratory indications (0.6 [0.2-1.3] vs 0.4 [0.1-0.9]; P = 0.002); gastrointestinal indications (0.09 [0-0.2] vs 0 [0-0.05]; P < 0.001); and other indications (0.05 [0-0.2] vs 0 [0-0.1]; P = 0.03). In the CFLD cohort, there was increased use of nasogastric (12.6% vs 5.4%; OR 2.51 [95% CI 1.06-6.46]; P = 0.03) and gastrostomy nutritional supplementation (22.9% vs 13.2%; OR 1.93 [95% CI 1.05-3.63]; P = 0.03). Additionally, the CFLD cohort had a higher frequency of bone diseases, osteopenia (26.5% vs 16.8%; OR 1.77 [95%CI 1.01-3.15]; P = 0.04) and osteoporosis (16.2% vs 8.4%; OR 2.1 [95% CI 1.01-4.52]; P = 0.04), as well as CF-related diabetes (38.5% vs 19.2%; OR 2.61 [95% CI 1.55-4.47]; P = 0.001). Patients with severe CFLD have greater disease burden, with higher number of hospitalizations (both respiratory and nonrespiratory indications), nutritional interventions, and are at higher risk of CF-related bone disease and diabetes.
Author Coffey, Michael J
Singh, Harveen
Ooi, Chee Y
Author_xml – sequence: 1
  givenname: Harveen
  surname: Singh
  fullname: Singh, Harveen
  organization: Department of Gastroenterology, Sydney Children's Hospital, Randwick
– sequence: 2
  givenname: Michael J
  surname: Coffey
  fullname: Coffey, Michael J
  organization: Discipline of Paediatrics, School of Women's and Children's Health, University of New South Wales, Sydney
– sequence: 3
  givenname: Chee Y
  surname: Ooi
  fullname: Ooi, Chee Y
  organization: Molecular and Integrative Cystic Fibrosis (miCF) Research Centre, Sydney Children's Hospital, High Street, Randwick, New South Wales, Australia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32443033$$D View this record in MEDLINE/PubMed
BookMark eNpNj8lKA0EURQtRzKB_IFI_0LGqX_W0jG0SAy26UFyGGl7jk3R1qOoI-Xtn8W7u4hwu3Ak79r1Hxi6kmElRFVd3D6uZ-Jc0r9QRG8sM8kSVQo7YJMbXD1CoTJyyEaRKgQAYs64-xIEsX5IJfaSYBNzqAR1v6A0Dv6GIOiKnyOcx9pa-2DMNL3ztbfhk7k-63geHnmvv-MK73gbyyOu-64MhRwNhPGMnrd5GPP_pKXtaLh7r26S5X63reZPspCiHBGRroQVVqSy1KVTKYG7KQmvIrDXCFaZClxqVY9mKTDswEqR2WIIp0rxUMGWX37u7venQbXaBOh0Om9_f8A7yvlxU
ContentType Journal Article
DBID NPM
DOI 10.1097/MPG.0000000000002694
DatabaseName PubMed
DatabaseTitle PubMed
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Diet & Clinical Nutrition
EISSN 1536-4801
ExternalDocumentID 32443033
Genre Journal Article
GroupedDBID ---
.-D
.3C
.55
.GJ
.XZ
.Z2
01R
0R~
1J1
1OC
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
77Y
7O~
AAAXR
AAGIX
AAHPQ
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AAUEB
AAWTL
AAXQO
AAYJJ
ABASU
ABBUW
ABDIG
ABJNI
ABPPZ
ABQWH
ABVCZ
ABXVJ
ABZAD
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACWDW
ACWRI
ACXNZ
ADBBV
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFDTB
AFEXH
AFFNX
AFFPM
AFSOK
AFUWQ
AGINI
AHBTC
AHOMT
AHQNM
AHRYX
AHVBC
AI.
AIJEX
AINUH
AITYG
AJIOK
AJNWD
AJNYG
AJZMW
AKULP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
ALUQN
AMJPA
AMKUR
AMNEI
AOHHW
AWKKM
BAWUL
BOYCO
BQLVK
BS7
C45
CS3
DCZOG
DIK
DIWNM
DU5
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
EMOBN
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GNXGY
GQDEL
H0~
HGLYW
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
JF9
JG8
JK3
JK8
K8S
KD2
KMI
L-C
MEWTI
N9A
NPM
N~7
N~B
N~M
O9-
OAG
OAH
OCUKA
ODA
ODMTH
OHYEH
OJAPA
OK1
OL1
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
R58
RIG
RLZ
S4R
S4S
SUPJJ
T8P
TEORI
TR2
TSPGW
V2I
VH1
VVN
W3M
WOQ
WOW
WXSBR
X3V
X3W
X7M
XXN
XYM
YOC
ZFV
ZGI
ZXP
ZZMQN
~KM
ID FETCH-LOGICAL-p108t-31fc3f349452c2394be6b87aa35ccb0d7b9ed2b46e8f05ad3b131ade83b726843
IngestDate Sat Sep 28 08:39:36 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p108t-31fc3f349452c2394be6b87aa35ccb0d7b9ed2b46e8f05ad3b131ade83b726843
PMID 32443033
ParticipantIDs pubmed_primary_32443033
PublicationCentury 2000
PublicationDate 2020-06-00
PublicationDateYYYYMMDD 2020-06-01
PublicationDate_xml – month: 06
  year: 2020
  text: 2020-06-00
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of pediatric gastroenterology and nutrition
PublicationTitleAlternate J Pediatr Gastroenterol Nutr
PublicationYear 2020
SSID ssj0007450
Score 2.4190133
Snippet Cystic fibrosis-related liver disease (CFLD) is the leading nonpulmonary cause of mortality in cystic fibrosis (CF). We evaluated and compared the burden of...
SourceID pubmed
SourceType Index Database
StartPage 796
Title Cystic Fibrosis-related Liver Disease is Associated With Increased Disease Burden and Endocrine Comorbidities
URI https://www.ncbi.nlm.nih.gov/pubmed/32443033
Volume 70
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaWVqp6QbQ8Wl7yAXGpUrJxEjtHtH3DFg6t6K3yK1WkNlnthgPw55mJ7WQprVTYQ7QbW14p35cZP2a-IeSdsZoVhqnI5PC6pVLoSOa8iAomrJRW5Urjie70ND86T08usovR6NdydkmrdvXPO_NK_gdVuAe4YpbsPyDbDwo34DvgC1dAGK4PwnjyA1WWdw5gydssqkXUJabADPIzBlugsCaevWDJ8gACtH3DjVewChiMDj9DJ5fO0B0l7Nem0ZgUiMaimavKdKqr90xjZ6HWx86VXLTzBjU-54OwUx3U_vutHPCV3VYOViWyQyLapClLt33uI_mHA6svTeUiA6z17sJvUyTxEE61a4NpzSMUq1m2va5oiOfYsiHlrs7tXwbeCQdPvx464Un_wXTc5e4A0-ymAx3miyl4aTa4uz4IMTQ9IquoooiFF_aOP_VunKdZHHItC_7hrr9cJ2thkFurkm52cvaEPPZ40I-OIxtkZOtNsr1X2Za-p1779ZqeBjA2ydrUB1U8JTeORvQ2jWhHI-oZQqsFHWhEkUa0p1HfydGIAvK0pxH9g0bPyPnB_tnkKPJVOKLZOBYtOOlSsxJVjLJEJ6xIlc2V4FKyTGsVG64KaxKV5laUcSbhvR-zsTRWMMVRSog9Jyt1U9stQnmZJTZVwmYKxssKYRIuNK6pSwPOTm-TF-4hXs6c1MpleLwv7215RdYHur0mK-38u30D88RWve3w_A0aBmpP
link.rule.ids 314,780,784,27924,27925
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cystic+Fibrosis-related+Liver+Disease+is+Associated+With+Increased+Disease+Burden+and+Endocrine+Comorbidities&rft.jtitle=Journal+of+pediatric+gastroenterology+and+nutrition&rft.au=Singh%2C+Harveen&rft.au=Coffey%2C+Michael+J&rft.au=Ooi%2C+Chee+Y&rft.date=2020-06-01&rft.eissn=1536-4801&rft.volume=70&rft.issue=6&rft.spage=796&rft_id=info:doi/10.1097%2FMPG.0000000000002694&rft_id=info%3Apmid%2F32443033&rft.externalDocID=32443033